Sofosbuvir CAS 1190307-88-0 Maʻemaʻe ≥99.0% (HPLC)
| inoa | Sofosbuvir |
| Nā huaʻōlelo like | GS-7977;PSI-7977 |
| Helu CAS | 1190307-88-0 |
| Kūlana Kūʻai | Ma ka waihona, ʻoi aku ka nui o ka hana a hiki i nā haneli kilogram |
| ʻĀpana Molekala | C22H29FN3O9P |
| Kaumaha Molecular | 529.45 |
| Lae hehee | 120.0~125.0 ℃ |
| ʻO ka mānoanoa | 1.41 |
| Ka hikiwawe | Hiki ke hoʻoheheʻe ʻia i DMF, DMSO, Ethanol |
| Kūlana Hoʻouna | Ma lalo o ka mahana wela |
| COA & MSDS | Loaʻa |
| Ke kumu | Shanghai, Kina |
| Ola Pahu | 36 mau mahina inā mālama pono ʻia |
| Brand | Kemika Ruifu |
| 'ikamu | Nā kikoʻī |
| Ka nana aku | Keʻokeʻo a i ka pauka kristal keʻokeʻo |
| ʻIkepili | HPLC;ʻO RT |
| Maʻemaʻe / Kaʻina Hanana | ≥99.0% (HPLC) |
| EE | ≥99.0% |
| Nalo ma ka maloo | ≤1.0% |
| Koena ma ka Ignition | ≤0.20% |
| Hoʻokahi haumia | ≤0.50% |
| Huina paumaele | ≤1.0% |
| Nā Metala Kaumaha | ≤20ppm |
| Nā mea hoʻoheheʻe koena | E hoʻokō i nā koi o nā kikoʻī |
| Methanol | ≤1500ppm |
| TBME | ≤2500ppm |
| Dichloromethane | ≤720ppm |
| Tetrahydrofuran | ≤720ppm |
| Toluene | ≤60ppm |
| Kūlana hoʻāʻo | Kūlana ʻoihana |
| Hoʻohana | ʻO Sofosbuvir (CAS: 1190307-88-0) i ka mālama ʻana i ka maʻi Hepatitis C (HCV) |
Pūʻolo: ʻO ka'ōmole, Aluminum foil eke, 25kg/Drum, aiʻole e like me ka makemake o ka mea kūʻai
Kūlana mālama:E mālama i loko o nā pahu i hoʻopaʻa ʻia ma kahi maloʻo a maloʻo;Pale mai ka malamalama, ka makū
ʻO Sofosbuvir (CAS: 1190307-88-0) (i kapa inoa ʻia ʻo PSI-797, GS-7977) he phosphoramidate prodrug a me ka nucleotide polymerase inhibitor no ka mālama ʻana i ka maʻi hepatitis C mau loa (HCV).Manaʻo ʻia e hoʻohana pū me nā lāʻau lapaʻau ʻē aʻe (e like me velpatasvir) no ka lāʻau lapaʻau mua no nā genotypes HCV 1, 2, 3, 4, 5, a me 6. Hoʻohana ʻia ia ma o ka hana ʻana ma ke ʻano he nucleotide analog inhibitor. hiki ke pale kūikawā i ka HCV NS5B (non-structural protein 5B) RNA-dependent RNA polymerase.
E kākau i kāu leka ma aneʻi a hoʻouna mai iā mākou